APP and Alzheimer disease: As argued above, it is highly plausible that the second AD stage-driving agent is iAβ generated in the AβPP-independent pathway; it is at the heart of Alzheimer’s pathology, and it is of great interest how AβPP-derived iAβ triggers its production.